{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:23:19Z","timestamp":1787908999769,"version":"build-2784847793"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) encompasses various cancers located in the rectosigmoid junction, rectum, and anus, as well as parts of the colon. Globally, CRC is the second leading cause of cancer-related mortality and the third most prevalent malignan-cy. The KRAS oncogene was found to be mutated in 30 to 50% of CRC cases, leading to dysregulated cellular functions. Furthermore, the connection between KRAS and P53 gene mutations and the incidence of both colorectal and breast cancer remains an area of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>This comprehensive narrative review was carried out by mining data from recog-nized databases, such as PubMed, Google Scholar, and ResearchGate. The purpose was to extensively explore and understand the association between the KRAS and P53 gene muta-tions and the prevalence of colorectal and breast cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mutation in the KRAS oncogene has been identified as a key player in cellular signaling pathways, including MAPK, PI3K, and PLD. Despite extensive research, gene therapies targeting these mutations have seen limited success, especially in codons 12, 13, 61, and 143.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Mutations in the KRAS and P53 genes, along with aberrant MDM2 expression, play pivotal roles in the onset and progression of colorectal cancer by disrupting key cellular signaling pathways, such as MAPK, PI3K, and PLD. Despite advancements in understand-ing these mechanisms, current gene therapy approaches have shown limited success, particu-larly in targeting KRAS codon mutations. This underscores the urgent need for innovative therapeutic strategies and further research to develop effective treatments for colorectal can-cer and its potential links to other malignancies, such as breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115680096349198250407100724","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T06:46:04Z","timestamp":1747118764000},"page":"490-500","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Association of KRAS and P53 Gene Mutations and MDM2 Expression with the Occurrence of Colorectal Cancer"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-8574","authenticated-orcid":true,"given":"Hany A.","family":"Al-Hussaniy","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Al-Nisour University College, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad I.","family":"Oraibi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Almanara College for Medical Sciences, Maisaan, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa Salam","family":"Al-Tameemi","sequence":"additional","affiliation":[{"name":"Dr. Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Hikmat","family":"Alburghaif","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena Akeel","family":"Naji","sequence":"additional","affiliation":[{"name":"Dr. Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Akeel","family":"Naji","sequence":"additional","affiliation":[{"name":"Dr. Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1038\/s41598-022-11089-9","volume":"12","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Xu Y.; Wang Y.; Alternative polyadenylation associated with prognosis and therapy in colorectal cancer. Sci Rep  2022,12(1),7036","journal-title":"Sci Rep"},{"key":"ref=2","first-page":"459","volume":"30","author":"Sahni V.","year":"2023","unstructured":"Sahni V.; Kumar A.; Identification of drug analogs as colorectal cancer inhibitors. J Popul Ther Clin Pharmacol  2023,30(12),459-475","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3329\/bjp.v17i3.60353","volume":"17","author":"Balcik-Ercin P.","year":"2022","unstructured":"Balcik-Ercin P.; Eckol, a potential inhibitor of aryl hydrocarbon receptor, inhibits proliferation and induces apoptosis in breast cancer cells. Bangladesh J Pharmacol  2022,17(3),84-91","journal-title":"Bangladesh J Pharmacol"},{"key":"ref=4","first-page":"671","volume":"56","author":"Dobre M.","year":"2015","unstructured":"Dobre M.; Dinu D.E.; Panaitescu E.; B\u00eerl\u0103 R.D.; Iosif C.I.; Boeriu M.; Constantinoiu S.; Ivan R.N.; Ardeleanu C.M.; Costache M.; KRAS gene mutations - prognostic factor in colorectal cancer? Rom J Morphol Embryol  2015,56(2)(Suppl.),671-678","journal-title":"Rom J Morphol Embryol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41379-020-0560-x","volume":"33","author":"Favazza L.A.","year":"2020","unstructured":"Favazza L.A.; Parseghian C.M.; Kaya C.; Nikiforova M.N.; Roy S.; Wald A.I.; Landau M.S.; Proksell S.S.; Dueker J.M.; Johnston E.R.; Brand R.E.; Bahary N.; Gorantla V.C.; Rhee J.C.; Pingpank J.F.; Choudry H.A.; Lee K.; Paniccia A.; Ongchin M.C.; Zureikat A.H.; Bartlett D.L.; Singhi A.D.; KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy. Mod Pathol  2020,33(9),1832-1843","journal-title":"Mod Pathol"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2021.61","author":"Cefal\u00ec M.","year":"2021","unstructured":"Cefal\u00ec M.; Epistolio S.; Palmarocchi M.C.; Frattini M.; De Dosso S.; Research progress on KRAS mutations in colorectal cancer. J Cancer Metastasis Treat  2021","journal-title":"J Cancer Metastasis Treat"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.53350\/pjmhs211582350","volume":"15","author":"Al-hassany H.A.","year":"2021","unstructured":"Al-hassany H.A.; Albu-rghaif A.H.A.; Naji M.; Tumor diagnosis by genetic markers protein P-53, p16, C-MYC, N-MYC, protein K-Ras, and gene her-2 Neu is this possible? Tumor diagnosis by genetic markers C-MYC, N-MYC, protein P-53, p16. Pak J Med Health Sci  2021,15(8),2350-2354","journal-title":"Pak J Med Health Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e33154","DOI":"10.1097\/MD.0000000000033154","volume":"102","year":"2023","unstructured":"Proceedings of the 26th Annual Meeting of the Portuguese Society of Human Genetics (SPGH - Sociedade Portuguesa de Gen\u00e9tica Humana) Coimbra, 17-19 November 2022. Medicine  2023,102(13),e33154","journal-title":"Medicine"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3329\/bjp.v18i2.65135","volume":"18","author":"Aitbaba A.","year":"2023","unstructured":"Aitbaba A.; Sokar Z.; Chait A.; Analgesic and anti-inflammatory effects of hydroalcoholic extract of Astragalus ibrahimianus. Bangladesh J Pharmacol  2023,18(2),41-48","journal-title":"Bangladesh J Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1158\/2159-8290.CD-16-0095","volume":"6","author":"Patnaik A.","year":"2016","unstructured":"Patnaik A.; Rosen L.S.; Tolaney S.M.; Tolcher A.W.; Goldman J.W.; Gandhi L.; Papadopoulos K.P.; Beeram M.; Rasco D.W.; Hilton J.F.; Nasir A.; Beckmann R.P.; Schade A.E.; Fulford A.D.; Nguyen T.S.; Martinez R.; Kulanthaivel P.; Li L.Q.; Frenzel M.; Cronier D.M.; Chan E.M.; Flaherty K.T.; Wen P.Y.; Shapiro G.I.; Efficacy and safety of abemaciclib, an inhibitor of CDK4 and CDK6, for patients with breast cancer, non-small cell lung cancer, and other solid tumors. Cancer Discov  2016,6(7),740-753","journal-title":"Cancer Discov"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1158\/1078-0432.CCR-16-2554","volume":"23","author":"Dong Z.Y.","year":"2017","unstructured":"Dong Z.Y.; Zhong W.Z.; Zhang X.C.; Su J.; Xie Z.; Liu S.Y.; Tu H.Y.; Chen H.J.; Sun Y.L.; Zhou Q.; Yang J.J.; Yang X.N.; Lin J.X.; Yan H.H.; Zhai H.R.; Yan L.X.; Liao R.Q.; Wu S.P.; Wu Y.L.; Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma. Clin Cancer Res  2017,23(12),3012-3024","journal-title":"Clin Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"Morgan E.","year":"2023","unstructured":"Morgan E.; Arnold M.; Gini A.; Lorenzoni V.; Cabasag C.J.; Laversanne M.; Vignat J.; Ferlay J.; Murphy N.; Bray F.; Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut  2023,72(2),338-344","journal-title":"Gut"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e048183","DOI":"10.1136\/bmjopen-2020-048183","volume":"11","author":"Schult A.L.","year":"2021","unstructured":"Schult A.L.; Botteri E.; Hoff G.; Randel K.R.; Dal\u00e9n E.; Eskeland S.L.; Holme \u00d8.; de Lange T.; Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: A cross-sectional study. BMJ Open  2021,11(7),e048183","journal-title":"BMJ Open"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.3390\/ijms241210201","volume":"24","author":"Orlandi G.","year":"2023","unstructured":"Orlandi G.; Roncucci L.; Carnevale G.; Sena P.; Different roles of apoptosis and autophagy in the development of human colorectal cancer. Int J Mol Sci  2023,24(12),10201","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.3390\/ijms221910260","volume":"22","author":"Stefani C.","year":"2021","unstructured":"Stefani C.; Miricescu D.; Stanescu-Spinu I.I.; Nica R.I.; Greabu M.; Totan A.R.; Jinga M.; Growth factors, PI3K\/AKT\/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: Where are we now? Int J Mol Sci  2021,22(19),10260","journal-title":"Int J Mol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"Wang H.","year":"2023","unstructured":"Wang H.; Guo M.; Wei H.; Chen Y.; Targeting p53 pathways: Mechanisms, structures and advances in therapy. Signal Transduct Target Ther  2023,8(1),92","journal-title":"Signal Transduct Target Ther"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3390\/cancers14143500","volume":"14","author":"Pereira M.","year":"2022","unstructured":"Pereira M.; Matuszewska K.; Glogova A.; Petrik J.; Mutant p53, the mevalonate pathway and the tumor microenvironment regulate tumor response to statin therapy. Cancers  2022,14(14),3500","journal-title":"Cancers"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"25560","DOI":"10.1073\/pnas.1912772117","volume":"117","author":"Smit W.L.","year":"2020","unstructured":"Smit W.L.; Spaan C.N.; Johannes de Boer R.; Ramesh P.; Martins Garcia T.; Meijer B.J.; Vermeulen J.L.M.; Lezzerini M.; MacInnes A.W.; Koster J.; Medema J.P.; van den Brink G.R.; Muncan V.; Heijmans J.; Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity. Proc Natl Acad Sci USA  2020,117(41),25560-25570","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.ctrv.2022.102433","volume":"109","author":"Janssen J.B.E.","year":"2022","unstructured":"Janssen J.B.E.; Medema J.P.; Gootjes E.C.; Tauriello D.V.F.; Verheul H.M.W.; Mutant RAS and the tumor microenvironment as dual therapeutic targets for advanced colorectal cancer. Cancer Treat Rev  2022,109(102433),102433","journal-title":"Cancer Treat Rev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.3390\/ijms23073706","volume":"23","author":"Shetu S.A.","year":"2022","unstructured":"Shetu S.A.; Bandyopadhyay D.; Small-molecule RAS inhibitors as anticancer agents: Discovery, development, and mechanistic studies. Int J Mol Sci  2022,23(7),3706","journal-title":"Int J Mol Sci"},{"key":"ref=21","author":"Ahmed D.F.","year":"2024","unstructured":"Ahmed D.F.; Role of hematopoietic growth factors as immune modulators (GM-CSF and IL-3) in newly diagnosed colorectal cancer patients and their correlation with p53 expression and global DNA methylation. Iraqi J Sci  2024","journal-title":"Iraqi J Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.24996\/ijs.2021.62.5.12","author":"Maaroof Z.A.","year":"2021","unstructured":"Maaroof Z.A.; Ibraheem S.R.; Ibrahim A.H.; A correlation study between hyperthyroidism and some apoptosis markers among Iraqi patients. Iraqi J Sci  2021,1484-1493","journal-title":"Iraqi J Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2174\/0115680096277956240119065938","volume":"24","author":"Lin H.","year":"2024","unstructured":"Lin H.; Hu S.; Li Y.; Li S.; Teng D.; Yang Y.; Liu B.; Du X.; H3K27ac-activated LncRNA NUTM2A-AS1 facilitated the progression of colorectal cancer cells via MicroRNA-126-5p\/FAM3C axis. Curr Cancer Drug Targets  2024,24(12),1222-1234","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2174\/0115680096274757231219072003","volume":"24","author":"Xing Y.","year":"2024","unstructured":"Xing Y.; Lin B.; Liu B.; Shao J.; Jin Z.; Tectorigenin inhibits glycolysis-induced cell growth and proliferation by modulating LncRNA CCAT2\/miR-145 pathway in colorectal cancer. Curr Cancer Drug Targets  2024,24(10),1071-1079","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.52142\/omujecm.40.1.5","volume":"40","author":"Al-haddad R.","year":"2023","unstructured":"Al-haddad R.; Majeed H.; The association between KRAS gene expression and breast tumors in a sample of Iraqi women. J Exp Clin Med  2023,40(1),23-26","journal-title":"J Exp Clin Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.55940\/medphar202340","volume":"2","author":"Bharti J.L.","year":"2023","unstructured":"Bharti J.L.; Wankhade A.; Morey P.; Ruikar P.; The role of obesity in cancer incidence, treatment, and outcomes. Med Pharm J  2023,2(3),181-192","journal-title":"Med Pharm J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"765","DOI":"10.36740\/WLek202204103","volume":"75","author":"Jumaa M.G.","year":"2022","unstructured":"Jumaa M.G.; Pattern of kras gene expression in Iraqi women ovarian carcinoma. Wiad Lek  2022,75(4),765-769","journal-title":"Wiad Lek"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.33435\/tcandtc.1399916","volume":"8","author":"Alkaya Y\u0131ld\u0131z C.","year":"2024","unstructured":"Alkaya Y\u0131ld\u0131z C.; Erkan S.; Investigation of anticancer properties of 2-benzylidene-1-indanone and its derivatives by DFT and molecular docking. Turk J Comput Theor Chem  2024,8(2),101-109","journal-title":"Turk J Comput Theor Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.33435\/tcandtc.1400422","volume":"8","author":"Sulliman EA","unstructured":"Sulliman EA; Ibrahim MA; Ibrahim A; Jasim RF; Molecular docking study on tamoxifen and toremifene's effects on the breast cancer receptors. Turkish Comput Theor Chem  ,8(4),62-69","journal-title":"Turkish Comput Theor Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.33435\/tcandtc.1249159","volume":"8","author":"Kirmiziay E.","year":"2024","unstructured":"Kirmiziay E.; Demi\u0307r R.; \u00d6\u011f\u00fct\u00e7\u00fc C.; Portakal H.S.; Discovery of repurposable drugs in the combination therapy of breast cancer: A virtual drug screening study. Turk J Comput Theor Chem  2024,8(1),40-53","journal-title":"Turk J Comput Theor Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"Li H.","year":"2020","unstructured":"Li H.; Yang Y.; Hong W.; Huang M.; Wu M.; Zhao X.; Applications of genome editing technology in the targeted therapy of human diseases: Mechanisms, advances and prospects. Signal Transduct Target Ther  2020,5(1),1","journal-title":"Signal Transduct Target Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.3390\/cancers13225599","volume":"13","author":"Kim H.J.","year":"2021","unstructured":"Kim H.J.; Lee H.N.; Jeong M.S.; Jang S.B.; Oncogenic KRAS: Signaling and drug resistance. Cancers  2021,13(22),5599","journal-title":"Cancers"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.trecan.2022.01.002","volume":"8","author":"Shui B.","year":"2022","unstructured":"Shui B.; La Rocca G.; Ventura A.; Haigis K.M.; Interplay between K-RAS and miRNAs. Trends Cancer  2022,8(5),384-396","journal-title":"Trends Cancer"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e1522","DOI":"10.32113\/wcrj_20203_1522","volume":"7","author":"Sadough A.","year":"2020","unstructured":"Sadough A.; Afshari M.; Rostami F.; Barzegari S.; Janbabaee G.; Tabrizi R.; A systematic review and meta-analysis on the prevalence of KRAS gene mutation in samples of colorectal cancer. WCRJ  2020,7,e1522","journal-title":"WCRJ"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-023-01441-4","volume":"8","author":"Yin G.","year":"2023","unstructured":"Yin G.; Huang J.; Petela J.; Jiang H.; Zhang Y.; Gong S.; Wu J.; Liu B.; Shi J.; Gao Y.; Targeting small GTPases: Emerging grasps on previously untamable targets, pioneered by KRAS. Signal Transduct Target Ther  2023,8(1),212","journal-title":"Signal Transduct Target Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.55940\/medphar202343","volume":"2","author":"Rahangdale P.C.","year":"2023","unstructured":"Rahangdale P.C.; Wankhade A.M.; Ganoderma lucidum ethanolic extract for the treatment of androgenic alopecia in rats with testosterone-induced Baldness. Med Pharm J  2023,2(2),107-120","journal-title":"Med Pharm J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.55940\/medphar202227","volume":"2","author":"Shaaban S.M.","year":"2023","unstructured":"Shaaban S.M.; Gaber Z.; Semary S.; Dewidar A.M.; Impact of Vitamin B12 on outcome of early stage luminal a and b breast cancer, single center experience. Med Pharm J  2023,2(1),17-27","journal-title":"Med Pharm J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3329\/bjp.v17i2.59809","volume":"17","author":"G\u00fc\u00e7l\u00fc E.","year":"2022","unstructured":"G\u00fc\u00e7l\u00fc E.; \u00c7\u0131nar Ayan \u0130.; Vural H.; Inhibitory effect of AK-7 mediates by apoptosis, increases DNA fragmentation and caspase-3 activity in human glioblastoma multiforme cells. Bangladesh J Pharmacol  2022,17(2),42-50","journal-title":"Bangladesh J Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ctro.2022.10.004","volume":"38","author":"Toulany M.","year":"2023","unstructured":"Toulany M.; Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives. Clin Transl Radiat Oncol  2023,38,6-14","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"111717","DOI":"10.1016\/j.biopha.2021.111717","volume":"140","author":"Meng M.","year":"2021","unstructured":"Meng M.; Zhong K.; Jiang T.; Liu Z.; Kwan H.Y.; Su T.; The current understanding on the impact of KRAS on colorectal cancer. Biomed Pharmacother  2021,140(111717),111717","journal-title":"Biomed Pharmacother"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41467-021-22125-z","volume":"12","author":"Cook J.H.","year":"2021","unstructured":"Cook J.H.; Melloni G.E.M.; Gulhan D.C.; Park P.J.; Haigis K.M.; The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nat Commun  2021,12(1),1808","journal-title":"Nat Commun"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.52711\/0974-360X.2022.00771","volume":"15","author":"Al-Hussaniy H.A.","year":"2022","unstructured":"Al-Hussaniy H.A.; Noori Mohammed Z.; Alburghaif A.H.; Akeel Naji M.; Panax ginseng as Antioxidant and Anti-inflammatory to reduce the Cardiotoxicity of Doxorubicin on rat module. Res J Pharm Technol  2022,15(10),4594-4600","journal-title":"Res J Pharm Technol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3897\/pharmacia.70.e109800","volume":"70","author":"Al-hussaniy H.A.","year":"2023","unstructured":"Al-hussaniy H.A.; Al-Shammari A.H.; Naji Sameer H.; Oraibi A.I.; The relationship between statin therapy and adipocytokine\/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study. Pharmacia  2023,70(3),581-585","journal-title":"Pharmacia"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"109735","DOI":"10.1016\/j.cbi.2021.109735","volume":"351","author":"Subramaniyan V.","year":"2022","unstructured":"Subramaniyan V.; Fuloria S.; Gupta G.; Kumar D.H.; Sekar M.; Sathasivam K.V.; Sudhakar K.; Alharbi K.S.; Al-Malki W.H.; Afzal O.; Kazmi I.; Al-Abbasi F.A.; Altamimi A.S.A.; Fuloria N.K.; A review on epidermal growth factor receptor\u2019s role in breast and non-small cell lung cancer. Chem Biol Interact  2022,351(109735),109735","journal-title":"Chem Biol Interact"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.33435\/tcandtc.1270359","volume":"7","author":"G\u00fcney E.","year":"2023","unstructured":"G\u00fcney E.; Sayi\u0307n K.; Structural, spectral, antibacterial and anticancer investigations of synthesized isoxazole derivatives. Turk J Comput Theor Chem  2023,7(3),30-41","journal-title":"Turk J Comput Theor Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7324\/JABB.2024.194161","volume":"12","author":"Sundari T.","year":"2024","unstructured":"Sundari T.; Kavitha R.; Gnanamangai B.M.; Saranya S.; Assessment of in vitro antioxidant properties and anticancer potential of Cucumis pubescens Willd. A medicinal fruit, utilizing human lung cancer cell line (A549). J Appl Biol Biotechnol  2024,12(6),185-192","journal-title":"J Appl Biol Biotechnol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7324\/JABB.2024.144233","volume":"12","author":"Patel F.","year":"2023","unstructured":"Patel F.; Upadhyay K.; Mammen D.; Robin E.; Ramachandran A.V.; Baxi D.; Phytochemical composition and antiproliferative activity of Opuntia elatior Mill.: In vitro and in silico studies on breast cancer cell line MCF-7. J Appl Biol Biotechnol  2023,12(1),117-127","journal-title":"J Appl Biol Biotechnol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1038\/s41388-021-01920-4","volume":"41","author":"Park Y.L.","year":"2022","unstructured":"Park Y.L.; Kim H.P.; Ock C.Y.; Min D.W.; Kang J.K.; Lim Y.J.; Song S.H.; Han S.W.; Kim T.Y.; EMT-mediated regulation of CXCL1\/5 for resistance to anti-EGFR therapy in colorectal cancer. Oncogene  2022,41(14),2026-2038","journal-title":"Oncogene"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.25122\/jml-2022-0356","volume":"16","author":"Hussein Z.R.","year":"2023","unstructured":"Hussein Z.R.; Omar S.K.; Alkazraji R.A.M.; Alsamarrai A.N.; Alrubaye H.S.; Al-hussaniy H.A.; Efficacy of Aflibercept as initial treatment for neovascular age-related macular degeneration in an Iraqi patient sample. J Med Life  2023,16(2),235-243","journal-title":"J Med Life"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.25122\/jml-2022-0091","volume":"16","author":"Altalebi R.R.","year":"2023","unstructured":"Altalebi R.R.; Al-hussaniy H.A.; Al-tameemi Z.S.; AL-Zobaidy, M.A.H.; Albu-Rghaif, A.H.; Alkuraishy, H.M.; Hedeab, G.M.; Azam, F.; Al-Samydai, A.M.; Naji, M.A. Non-alcoholic fatty liver disease: Relation to juvenile obesity, lipid profile, and hepatic enzymes. J Med Life  2023,16(1),42-47","journal-title":"J Med Life"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.52711\/0974-360X.2023.00573","volume":"16","author":"Alshamary I.O.","year":"2023","unstructured":"Alshamary I.O.; Anwer Z.M.; Hafedh A.H.; Comparison of the effects of Methotrexate and Etanercept on RANKL and OPG as Bone Metabolism Biomarkers in patients with Rheumatoid Arthritis. Res J Pharm Technol  2023,16(7),3468-3474","journal-title":"Res J Pharm Technol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.55940\/medphar20227","volume":"1","author":"Al-hussaniy H.A.","year":"2022","unstructured":"Al-hussaniy H.A.; AL-Biati, H.A. The role of Leptin Hormone, Neuropeptide Y, Ghrelin and Leptin\/Ghrelin ratio in obesogenesis. Med Pharm J  2022,1(2),12-23","journal-title":"Med Pharm J"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.31925\/farmacia.2023.4.2","volume":"71","author":"Al-Hussaniy H.A.","year":"2023","unstructured":"Al-Hussaniy H.A.; Pharmacological properties of Spirulina species: Hepatoprotective, antioxidant and anticancer effects. Farmacia  2023,71(4),670-678","journal-title":"Farmacia"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.31557\/APJCP.2022.23.9.3151","volume":"23","year":"2022","unstructured":"Al-hussaniy, The effect of MicroRNA-409-3p for treatment and response to tumor proliferation of lung cancer cell lines (in vitro). Asian Pac J Cancer Prev  2022,23(9),3151-3156","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.2147\/CMAR.S292992","volume":"13","author":"Guo T.","year":"2021","unstructured":"Guo T.; Dong X.; Xie S.; Zhang L.; Zeng P.; Zhang L.; Cellular mechanism of gene mutations and potential therapeutic targets in ovarian cancer. Cancer Manag Res  2021,13,3081-3100","journal-title":"Cancer Manag Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"Haki M.","year":"2024","unstructured":"Haki M.; AL-Biati H.A.; Al-Tameemi Z.S.; Ali I.S.; Al-hussaniy H.A.; Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment. Medicine  2024,103(8),e37297","journal-title":"Medicine"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e18028","DOI":"10.1590\/s2175-97902018000318028","volume":"54","author":"Rengasamy G.","year":"2018","unstructured":"Rengasamy G.; Venkataraman A.; Veeraraghavan V.P.; Jainu M.; Cytotoxic and apoptotic potential of Myristica fragrans Houtt. (mace) extract on human oral epidermal carcinoma KB cell lines. Braz J Pharm Sci  2018,54(3),e18028","journal-title":"Braz J Pharm Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/S1984-82502010000100006","volume":"46","author":"Louren\u00e7o A.V.","year":"2010","unstructured":"Louren\u00e7o A.V.; Women cancer prevention and pharmaceutical contribution. Braz J Pharm Sci  2010,46(1),45-52","journal-title":"Braz J Pharm Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"354","DOI":"10.31415\/bjns.v3i2.101","volume":"3","author":"Jain S.","year":"2020","unstructured":"Jain S.; Arora P.; Popli H.; A comprehensive review on Citrus aurantifolia essential oil: Its phytochemistry and pharmacological aspects. Brazil. J Nat Sci  2020,3(2),354","journal-title":"J Nat Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4149\/BLL_2024_97","volume":"125","author":"Al-Hussaniy H.A.","year":"2024","unstructured":"Al-Hussaniy H.A.; J Al-Zobaidy M.; Effects of Mdm2 inhibitors on cellular viability of breast cancer cell lines HP100, MCF7. Bratisl Med J  2024,125(10),627-634","journal-title":"Bratisl Med J"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7324\/JABB.2024.171563","volume":"12","author":"Chauhan A.","year":"2024","unstructured":"Chauhan A.; Kalra K.; Kalra S.; AZIN1-centric dynamic network biomarker of tipping point in non-small cell lung cancer metastasis. J Appl Biol Biotechnol  2024,12(3),205-213","journal-title":"J Appl Biol Biotechnol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.31557\/APJCP.2024.25.6.2133","volume":"25","author":"Al-hussaniy H.","year":"2024","unstructured":"Al-hussaniy H.; AL-Zobaidy M.; Cytotoxic effect of YH239-EE and its enantiomer on MCF7 cell line. Asian Pac J Cancer Prev  2024,25(6),2133-2138","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=63","first-page":"1","volume":"1","author":"Hadi H.M.","year":"2021","unstructured":"Hadi H.M.; Shahada A.R.; Hussein N.M.; Hussein E.H.; Doxorubicin side effects and its uses a new update: A narrative review. Arab J Drug Res  2021,1(1),1-6","journal-title":"Arab J Drug Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.2174\/1389201024666230202160504","volume":"24","author":"Ali D.S.","year":"2023","unstructured":"Ali D.S.; Othman H.O.; Anwer E.T.; The advances in chitosan-based drug delivery systems for colorectal cancer: A narrative review. Curr Pharm Biotechnol  2023,24(12),1554-1559","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/0113892010242028231002075512","volume":"25","author":"Deshmukh R.","year":"2024","unstructured":"Deshmukh R.; Prajapati M.; Harwansh R.K.; Management of colorectal cancer using nanocarriers-based drug delivery for herbal bioactives: Current and emerging approaches. Curr Pharm Biotechnol  2024,25(5),599-622","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1568009622666220517092340","volume":"22","author":"Althenayyan S.","year":"2022","unstructured":"Althenayyan S.; AlGhamdi A.; AlMuhanna M.H.; Hawsa E.; Aldeghaither D.; Iqbal J.; Mohammad S.; Aziz M.A.; Modulation of ATP8B1 gene expression in colorectal cancer cells suggest its role as a tumor suppressor. Curr Cancer Drug Targets  2022,22(7),577-590","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2174\/0113892010270975231208113157","volume":"25","author":"Chauhan S.","year":"2024","unstructured":"Chauhan S.; Sharma S.; Recent approaches on molecular markers, treatment and novel drug delivery system used for the management of colorectal cancer: A comprehensive review. Curr Pharm Biotechnol  2024,25(15),1969-1985","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2174\/0118715206323900240807110122","volume":"24","author":"Song Q.","year":"2024","unstructured":"Song Q.; Zheng Y.; Zhong G.; Wang S.; He C.; Li M.; Application of nanoparticles in the diagnosis and treatment of colorectal cancer. Anticancer Agents Med Chem  2024,24(18),1305-1326","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2174\/0118715206288807240527165444","volume":"24","author":"Althagafi H.A.","year":"2024","unstructured":"Althagafi H.A.; The potential anticancer potency of kolaviron on colorectal adenocarcinoma (Caco-2) cells. Anticancer Agents Med Chem  2024,24(15),1097-1108","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2174\/0118715206296355240325113920","volume":"24","author":"Bani N.","year":"2024","unstructured":"Bani N.; Rahmani F.; Shakour N.; Amerizadeh F.; Khalili-Tanha G.; Khazaei M.; Hassanian S.M.; Kerachian M.A.; Abbaszadegan M.R.; Mojarad M.; Hadizadeh F.; Ferns G.A.; Avan A.; Wortmannin inhibits cell growth and induces apoptosis in colorectal cancer cells by suppressing the PI3K\/AKT pathway. Anticancer Agents Med Chem  2024,24(12),916-927","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2174\/1389201022666210910094827","volume":"23","author":"Rezaee M.A.","year":"2022","unstructured":"Rezaee M.A.; Nouri R.; Hasani A.; Shirazi K.M.; Alivand M.R.; Sepehri B.; Sotoodeh S.; Hemmati F.; Escherichia coli and colorectal cancer: Unfolding the enigmatic relationship. Curr Pharm Biotechnol  2022,23(10),1257-1268","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.30539\/ijvm.v46i2.1554","volume":"46","author":"K Tarab M.","year":"2022","unstructured":"K Tarab M.; M AL-Rekabi F.; Therapeutic trial of modified levofloxacin (MOLVX) against induced colorectal Aberrant Crypt Foci (precancerous tissue) in mice. Iraqi J Vet Med  2022,46(2),53-65","journal-title":"Iraqi J Vet Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2174\/1389201022666210810104226","volume":"23","author":"Ghani S.","year":"2022","unstructured":"Ghani S.; Deravi N.; Pirzadeh M.; Rafiee B.; Gatabi Z.R.; Bandehpour M.; Yarian F.; Antibody fragment and targeted colorectal cancer therapy: A global systematic review. Curr Pharm Biotechnol  2022,23(8),1061-1071","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2174\/0115680096290709240102064645","volume":"24","author":"Wang H.","year":"2024","unstructured":"Wang H.; An Z.; Liu Y.; Ding G.; Deng G.; Ji C.; Gong Y.; Clinical significance of HHLA2 as a novel therapeutic target for colorectal cancer. Curr Cancer Drug Targets  2024,24(11),1177-1186","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"801","DOI":"10.33899\/ijvs.2024.149230.3638","volume":"38","author":"Yahya T.A.","year":"2024","unstructured":"Yahya T.A.; Mousa Y.J.; Molecular effects of nimesulide and aspirin on caspase-3, PPAR-\u03b1, and COX-2 gene expression in mice. Iraqi J Vet Sci  2024,38(4),801-807","journal-title":"Iraqi J Vet Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"715","DOI":"10.33899\/ijvs.2024.148257.3571","volume":"38","author":"Alayash A.A.","year":"2024","unstructured":"Alayash A.A.; Abed F.M.; The novel genomic DNA integrity in neutral buffer formalin, Bouin\u2019s fluid, and zinc formalin fixatives: A comparative study. Iraqi J Vet Sci  2024,38(3),715-719","journal-title":"Iraqi J Vet Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2174\/0115680096273465231201115839","volume":"24","author":"Karbalaee R.","year":"2024","unstructured":"Karbalaee R.; Mehdizadeh S.; Ghaleh H.E.G.; Izadi M.; Kondori B.J.; Dorostkar R.; Hosseini S.M.; The effects of mesenchymal stem cells loaded with oncolytic Coxsackievirus A21 on mouse models of colorectal cancer. Curr Cancer Drug Targets  2024,24(9),967-974","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=78","first-page":"417","volume":"20","author":"Mahdi N.F.","year":"2024","unstructured":"Mahdi N.F.; Al-Sultani M.M.; Thermal properties of fragmented human kidney stones by Ho: YAG laser. Iraqi J Appl Phys  2024,20(2B),417-421","journal-title":"Iraqi J Appl Phys"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4103\/MJBL.MJBL_1193_23","volume":"21","author":"Hassoon H.J.","year":"2024","unstructured":"Hassoon H.J.; Muhsin J.M.; Investigate the relationship between the presence of jcv dna and the immunohistochemical expression of CK2 0, CK7, and CDX2 in colorectal cancer. Med J Babylon  2024,21(3),718-723","journal-title":"Med J Babylon"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/MJBL.MJBL_315_23","volume":"21","author":"Mamoori A.J.","year":"2024","unstructured":"Mamoori A.J.; Alkafaji H.A.; Linking the defect of gamma-aminobutyric acid type a receptor subunit delta gene to the microsatellite instability in colorectal cancer. Med J Babylon  2024,21(2),276-279","journal-title":"Med J Babylon"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.31557\/APJCP.2024.25.11.3761","volume":"25","author":"Kravtsova E.","year":"2024","unstructured":"Kravtsova E.; Tsyganov M.; Tsydenova I.; Dolgasheva D.; Gaptulbarova K.; Litviakov N.; Ibragimova M.; Markers of predicting response to neoadjuvant chemotherapy in breast cancer: New in molecular oncology. Asian Pac J Cancer Prev  2024,25(11),3761-3769","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.31557\/APJCP.2024.25.11.3913","volume":"25","author":"Alqudah T.","year":"2024","unstructured":"Alqudah T.; Ismail S.; Abdeen D.; Ababneh N.; Khatib F.; Al-Essa M.; Hawari F.; Obeidat N.; Alkayed N.; Shafagoj Y.; The association between EPHX1 gene polymorphisms and lung cancer among jordanian people. Asian Pac J Cancer Prev  2024,25(11),3913-3919","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/MJBL.MJBL_348_22","volume":"21","author":"Alezzi M.J.","year":"2024","unstructured":"Alezzi M.J.; Alani K.H.; Alezzi J.I.; Epidemiology of colorectal polyps in Iraqi patients. Med J Babylon  2024,21(3),506-510","journal-title":"Med J Babylon"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.31557\/APJCP.2024.25.11.3851","volume":"25","author":"Daryanto B.","year":"2024","unstructured":"Daryanto B.; Wibowo E.; Prayudi N.; Indra A.; Budaya T.; Nurhadi P.; Kustono A.; Seputra K.; Yudhanto H.; Effects of conjugated linoleic acid (CLA) supplementation and exposure of cigarette smoke on Bcl-2, P53 protein, and TNF-\u03b1 expression in the epitels of wistar rats (Rattus Norvegicus) bladder. Asian Pac J Cancer Prev  2024,25(11),3851-3858","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.31557\/APJCP.2024.25.7.2337","volume":"25","author":"Park J.S.","year":"2024","unstructured":"Park J.S.; Lee S.S.; Choi Y.S.; The effects of KRAS mutations on the prognosis of rectal cancer following neoadjuvant chemoradiotherapy and surgery. Asian Pac J Cancer Prev  2024,25(7),2337-2342","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"600","DOI":"10.25122\/jml-2021-0153","volume":"14","author":"Akeel Al-hussaniy H.","year":"2021","unstructured":"Akeel Al-hussaniy H.; Hikmate Alburghaif A.; Akeel Naji M.; Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J Med Life  2021,14(5),600-605","journal-title":"J Med Life"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5144\/0256-4947.2022.252","volume":"42","author":"Ibrahem S.","year":"2022","unstructured":"Ibrahem S.; Ahmed H.; Zangana S.; Trends in colorectal cancer in Iraq over two decades: Incidence, mortality, topography and morphology. Ann Saudi Med  2022,42(4),252-261","journal-title":"Ann Saudi Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"905828","DOI":"10.3389\/fphar.2022.905828","volume":"13","author":"Al-Kuraishy H.M.","year":"2022","unstructured":"Al-Kuraishy H.M.; Al-Hussaniy H.A.; Al-Gareeb A.I.; Negm W.A.; El-Kadem A.H.; Batiha G.E.; N Welson N.; Mostafa-Hedeab, G.; Qasem, A.H.; Conte-Junior, C.A. Combination of Panax ginseng CA Mey and febuxostat boasted cardioprotective effects against doxorubicin-induced acute cardiotoxicity in rats. Front Pharmacol  2022,13,905828","journal-title":"Front Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"491","DOI":"10.25122\/jml-2022-0322","volume":"16","author":"Al-hussaniy H.A.","year":"2023","unstructured":"Al-hussaniy H.A.; Alburghaif A.H.; alkhafaje, Z.; AL-Zobaidy, M.A.H.J.; Alkuraishy, H.M.; Mostafa-Hedeab, G.; Azam, F.; Al-Samydai, A.M.; Al-tameemi, Z.S.; Naji, M.A. Chemotherapy-induced cardiotoxicity: A new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs. J Med Life  2023,16(4),491-500","journal-title":"J Med Life"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/j.celrep.2017.03.001","volume":"18","author":"Green C.D.","year":"2017","unstructured":"Green C.D.; Huang Y.; Dou X.; Yang L.; Liu Y.; Han J.D.J.; Impact of dietary interventions on noncoding RNA networks and mRNAs encoding chromatin-related factors. Cell Rep  2017,18(12),2957-2968","journal-title":"Cell Rep"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.21037\/tcr-24-366","volume":"13","author":"Mao X.","year":"2024","unstructured":"Mao X.; Yang S.; Zhang Y.; Yang H.; Yan D.; Zhang L.; The role of chromatin modulator DPY30 in glucose metabolism of colorectal cancer cells. Transl Cancer Res  2024,13(8),4205-4218","journal-title":"Transl Cancer Res"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.PEDIATRIC24-A080","volume":"84","author":"Alimova I.I.","year":"2024","unstructured":"Alimova I.I.; Murdock G.; Pierce A.M.; Wang D.; Dahl N.; Venkataraman S.; Vibhakar R.; Abstract A080 PRC1\/BMI1 activity alters chromatin accessibility to regulate differentiation in atypical teratoid rhabdoid tumors. Cancer Res  (17_Supplement)(Suppl.), A080-A080.2024,84","journal-title":"Cancer Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-024-02015-w","volume":"23","author":"Zhuang K.","year":"2024","unstructured":"Zhuang K.; Wang L.; Lu C.; Liu Z.; Yang D.; Zhong H.; Zou J.; Fahira A.; Wang J.; Huang Z.; Assessment of SWI\/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancer. Mol Cancer  2024,23(1),176","journal-title":"Mol Cancer"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.trecan.2024.05.005","volume":"10","author":"Neefjes J.","year":"2024","unstructured":"Neefjes J.; Gurova K.; Sarthy J.; Szab\u00f3 G.; Henikoff S.; Chromatin as an old and new anticancer target. Trends Cancer  2024,10(8),696-707","journal-title":"Trends Cancer"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"Duan R.","year":"2020","unstructured":"Duan R.; Du W.; Guo W.; EZH2: A novel target for cancer treatment. J Hematol Oncol  2020,13(1),104","journal-title":"J Hematol Oncol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","volume":"5","author":"Huang A.","year":"2020","unstructured":"Huang A.; Yang X.R.; Chung W.Y.; Dennison A.R.; Zhou J.; Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther  2020,5(1),146","journal-title":"Signal Transduct Target Ther"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"Yang K.","year":"2022","unstructured":"Yang K.; Wu Z.; Zhang H.; Zhang N.; Wu W.; Wang Z.; Dai Z.; Zhang X.; Zhang L.; Peng Y.; Ye W.; Zeng W.; Liu Z.; Cheng Q.; Glioma targeted therapy: Insight into future of molecular approaches. Mol Cancer  2022,21(1),39","journal-title":"Mol Cancer"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"20503121211034366","DOI":"10.1177\/20503121211034366","volume":"9","author":"Debela D.T.","year":"2021","unstructured":"Debela D.T.; Muzazu S.G.Y.; Heraro K.D.; Ndalama M.T.; Mesele B.W.; Haile D.C.; Kitui S.K.; Manyazewal T.; New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med  2021,9,20503121211034366","journal-title":"SAGE Open Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"121878","DOI":"10.1016\/j.ijpharm.2022.121878","volume":"624","author":"Yasamineh S.","year":"2022","unstructured":"Yasamineh S.; Yasamineh P.; Ghafouri Kalajahi H.; Gholizadeh O.; Yekanipour Z.; Afkhami H.; Eslami M.; Hossein Kheirkhah A.; Taghizadeh M.; Yazdani Y.; Dadashpour M.; A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm  2022,624,121878","journal-title":"Int J Pharm"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.3390\/cancers13184570","volume":"13","author":"Anjum S.","year":"2021","unstructured":"Anjum S.; Hashim M.; Malik S.A.; Khan M.; Lorenzo J.M.; Abbasi B.H.; Hano C.; Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment. Cancers  2021,13(18),4570","journal-title":"Cancers"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"Zhong L.","year":"2021","unstructured":"Zhong L.; Li Y.; Xiong L.; Wang W.; Wu M.; Yuan T.; Yang W.; Tian C.; Miao Z.; Wang T.; Yang S.; Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal Transduct Target Ther  2021,6(1),201","journal-title":"Signal Transduct Target Ther"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680096349198250407100724","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/241949\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680096349198250407100724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:10:34Z","timestamp":1786511434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/241949\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680096349198250407100724","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}